Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Ibanez

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|February 2, 2023
Synapse-tuned CARs enhance immune cell anti-tumor activityPeter J Chockley, Jorge Ibanez-Vega, Giedre Krenciute, et al.
Research Square|February 27, 2026
Antigen Specificity and Cell Engineering Determine CAR T Cell Efficacy in Group 3 MedulloblastomaGiedre Krenciute, Meghan Ward, Justine Fouliard, et al.
Nature Communications|February 4, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptorChiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin, et al.
STAR Protocols|November 3, 2024
Protocol for live-cell imaging of immune synapse formation and activation of CAR T cells against cancer cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Cell Reports. Medicine|November 22, 2023
GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Journal for Immunotherapy of Cancer|March 30, 2026
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGsJorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio, et al.
Journal for Immunotherapy of Cancer|November 21, 2024
IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumorsElizabeth Wickman, Shannon Lange, Jessica Wagner, et al.
Cell Reports. Medicine|February 13, 2024
Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificityJaquelyn T Zoine, Kalyan Immadisetty, Jorge Ibanez-Vega, et al.
Nature Biomedical Engineering|November 30, 2023
Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signallingMatthew Bell, Shannon Lange, Besian I Sejdiu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|February 2, 2023
Synapse-tuned CARs enhance immune cell anti-tumor activityPeter J Chockley, Jorge Ibanez-Vega, Giedre Krenciute, et al.
Research Square|February 27, 2026
Antigen Specificity and Cell Engineering Determine CAR T Cell Efficacy in Group 3 MedulloblastomaGiedre Krenciute, Meghan Ward, Justine Fouliard, et al.
Nature Communications|February 4, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptorChiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin, et al.
STAR Protocols|November 3, 2024
Protocol for live-cell imaging of immune synapse formation and activation of CAR T cells against cancer cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Cell Reports. Medicine|November 22, 2023
GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cellsJorge Ibanez, Nikhil Hebbar, Unmesha Thanekar, et al.
Journal for Immunotherapy of Cancer|March 30, 2026
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGsJorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio, et al.
Journal for Immunotherapy of Cancer|November 21, 2024
IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumorsElizabeth Wickman, Shannon Lange, Jessica Wagner, et al.
Cell Reports. Medicine|February 13, 2024
Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificityJaquelyn T Zoine, Kalyan Immadisetty, Jorge Ibanez-Vega, et al.
Nature Biomedical Engineering|November 30, 2023
Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signallingMatthew Bell, Shannon Lange, Besian I Sejdiu, et al.
Pageof 1